Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AtriCure (ATRC) Invested Capital (2016 - 2025)

Historic Invested Capital for AtriCure (ATRC) over the last 17 years, with Q3 2025 value amounting to $538.4 million.

  • AtriCure's Invested Capital rose 218.0% to $538.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $538.4 million, marking a year-over-year increase of 218.0%. This contributed to the annual value of $463.8 million for FY2024, which is 242.81% down from last year.
  • According to the latest figures from Q3 2025, AtriCure's Invested Capital is $538.4 million, which was up 218.0% from $526.4 million recorded in Q2 2025.
  • In the past 5 years, AtriCure's Invested Capital registered a high of $548.5 million during Q3 2021, and its lowest value of $385.1 million during Q2 2021.
  • Its 5-year average for Invested Capital is $499.2 million, with a median of $516.7 million in 2022.
  • Data for AtriCure's Invested Capital shows a peak YoY increase of 7207.63% (in 2021) and a maximum YoY decrease of 762.34% (in 2021) over the last 5 years.
  • Quarter analysis of 5 years shows AtriCure's Invested Capital stood at $494.7 million in 2021, then decreased by 5.63% to $466.9 million in 2022, then rose by 1.8% to $475.3 million in 2023, then dropped by 2.43% to $463.8 million in 2024, then rose by 16.08% to $538.4 million in 2025.
  • Its last three reported values are $538.4 million in Q3 2025, $526.4 million for Q2 2025, and $516.5 million during Q1 2025.